CYP 0.00% 19.0¢ cynata therapeutics limited

Ann: NHMRC Funding for Osteoarthritis Trial Using Cymerus MSCs, page-63

  1. 518 Posts.
    lightbulb Created with Sketch. 270

    Can we just be positive for a while given this huge news. 

    Yes, I think I’ve heard the point re management loans to exercise options...it’s done, doesn’t have to be brought up numerous times every day. Please feel comfort in that your point has been made load and clear and we’re very aware of it moving forward. 


    But hey, we need retail investors because almost all institutions will require more liquidity, so what’s the solution...complain about not having new retail and at the same time flood HC (which most new retail investors will  read) with in your opinion a past negative event in the company, that by the way was supported by the majority of shareholders. I understand the loan for options upset people and that it was not the best solution, but also not the worst solution. 


    I’ve stayed in and planning to move to phase 2 with the company, likely in three applications, and perhaps others may be progressing ahead of expectations that we aren’t aware off, as was the case with yesterday’s news. 

 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
19.0¢
Change
0.000(0.00%)
Mkt cap ! $34.32M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 23330 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
20.5¢ 43657 1
View Market Depth
Last trade - 08.30am 05/09/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.